Article
OpenOncology: An Open-Source Framework for Evidence-Based Drug Matching and De Novo Custom Drug Discovery in Precision Oncology
2026-05-18
Abstract excerpt
<title>Abstract</title> <p>Background Precision oncology depends on rapid, evidence-based matching of tumor variants to approved therapies. However, two compounding problems limit access for most patients worldwide: first, the interpretation infrastructure remains locked behind institutional subscriptions; second, even well-resourced precision oncology pipelines return empty outputs when no approved or repurpose...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dcd67f55-39d2-5881-885e-7a393598829d
- DOI
- 10.21203/rs.3.rs-9707913/v1
